ARTICLE | Company News
MediSix Therapeutics Pte. Ltd. (Singapore) obtained an exclusive license to patent and technology rights from the National University of Singapore to develop therapies for T cell lymphoma and leukemi...
MediSix Therapeutics Pte. Ltd. (Singapore) obtained an exclusive license to patent and technology rights from the National University of Singapore to develop therapies for T cell lymphoma and leukemi...